{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:13Z","timestamp":1792611673034,"version":"4.5.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/wno.0b013e31825662f1","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T16:15:33Z","timestamp":1337616933000},"page":"154-166","source":"Crossref","is-referenced-by-count":56,"title":["Neuromyelitis Optica"],"prefix":"10.1097","volume":"32","author":[{"given":"Mark J.","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Wingerchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210126","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/1352458510382324","article-title":"Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.","volume":"16","author":"Parratt","year":"2010","journal-title":"Mult Scler"},{"key":"R2-14-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-med-043010-193843","article-title":"Aquaporins in clinical medicine.","volume":"63","author":"Verkman","year":"2012","journal-title":"Ann Rev Med"},{"key":"R3-14-20210126","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","article-title":"Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1M23 isoforms and orthogonal arrays.","volume":"286","author":"Crane","year":"2011","journal-title":"J Biol Chem"},{"key":"R4-14-20210126","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding water channel extracellular domain in neuromyelitis optica.","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"R5-14-20210126","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devics neuromyelitis optica.","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"R6-14-20210126","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions in neuromyelitis optica: distinction from multiple sclerosis.","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"R7-14-20210126","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"R9-14-20210126","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006982-199414050-00010","article-title":"Retinal pathologic changes in multiple sclerosis.","volume":"14","author":"Kerrison","year":"1994","journal-title":"Retina"},{"key":"R10-14-20210126","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","article-title":"Devics neuromyelitis optica: a clinicopathological study of 8 patients.","volume":"34","author":"Mandler","year":"1993","journal-title":"Ann Neurol"},{"key":"R11-14-20210126","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/jnnp.2008.166207","article-title":"Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis.","volume":"80","author":"Green","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R12-14-20210126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"R13-14-20210126","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"R14-14-20210126","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"R15-14-20210126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","article-title":"Neuromyelitis optica: passive transfer to rats by human immunoglobulin.","volume":"386","author":"Kinoshita","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-14-20210126","first-page":"1033","article-title":"Myelite subaigue compliquee de neurite optique.","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med"},{"key":"R18-14-20210126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R19-14-20210126","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF and MRI findings in Devics neuromyelitis optica.","volume":"60","author":"ORiordan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"R20-14-20210126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3928\/0191-3913-19960901-05","article-title":"Pediatric Devics neuromyelitis optica.","volume":"33","author":"Jeffery","year":"1996","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R21-14-20210126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"R22-14-20210126","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.0b013e3181f39a66","article-title":"Long-term follow-up of neuromyelitis optica with a pediatric onset.","volume":"75","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"R23-14-20210126","doi-asserted-by":"crossref","first-page":"e1039","DOI":"10.1542\/peds.2007-2758","article-title":"Spectrum of pediatric neuromyelitis optica.","volume":"122","author":"Lotze","year":"2008","journal-title":"Pediatrics"},{"key":"R24-14-20210126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1590\/S0004-282X2011000100008","article-title":"NMO in pediatric patients. Brain involvement and clinical expression.","volume":"69","author":"Pena","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"R25-14-20210126","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/brain\/awh624","article-title":"Role of return migration in the emergence of multiple sclerosis in the French West Indies.","volume":"128","author":"Cabre","year":"2005","journal-title":"Brain"},{"key":"R26-14-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba.","volume":"256","author":"Cabrera-Gomez","year":"2009","journal-title":"J Neurol"},{"key":"R27-14-20210126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population.","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol"},{"key":"R28-14-20210126","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians.","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"R29-14-20210126","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J Neurol"},{"key":"R30-14-20210126","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1212\/WNL.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies).","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"R32-14-20210126","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1212\/WNL.0b013e3181fc2823","article-title":"Neuromyelitis optica and NMO-IgG in European pediatric patients.","volume":"75","author":"Huppke","year":"2010","journal-title":"Neurology"},{"key":"R33-14-20210126","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker for neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R34-14-20210126","first-page":"1404","article-title":"Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment Neurology.","volume":"75","author":"Weinshenker","year":"2010","journal-title":""},{"key":"R35-14-20210126","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","article-title":"Familial neuromyelitis optica.","volume":"75","author":"Matiello","year":"2010","journal-title":"Neurology"},{"key":"R36-14-20210126","first-page":"571","article-title":"Is neuromyelitis optica associated with human leukocyte antigen Mult Scler.","volume":"15","author":"Zephir","year":"2009","journal-title":""},{"key":"R37-14-20210126","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1 0501 is associated with susceptibility toanti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese.","volume":"233","author":"Wang","year":"2011","journal-title":"J Neuroimmunol"},{"key":"R38-14-20210126","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1212\/WNL.0b013e31822f045b","article-title":"Genetic analysis of aquaporin-4 in neuromyelitis optica.","volume":"77","author":"Matiello","year":"2011","journal-title":"Neurology"},{"key":"R39-14-20210126","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica.","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"R40-14-20210126","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival.","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"R41-14-20210126","first-page":"918","article-title":"Confavreux C, de Seze J; Group Members for NOMADMUS and CF-SEP.","volume":"68","author":"Collongues","year":"2011","journal-title":"A benign form of neuromyelitis optica: does it exist Arch Neurol"},{"key":"R42-14-20210126","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jnnp.2007.143529","article-title":"Relapsing neuromyelitis optica: long term history and clinical predictors of death.","volume":"80","author":"Cabre","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R43-14-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":"Comi G; Italian Devics Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devics neuromyelitis optica.","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J Neurol"},{"key":"R44-14-20210126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica.","volume":"126","author":"Papais-Alvarenga","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R45-14-20210126","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients.","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"R46-14-20210126","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"key":"R47-14-20210126","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica.","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"R48-14-20210126","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","article-title":"Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.","volume":"78","author":"Waters","year":"2012","journal-title":"Neurology"},{"key":"R49-14-20210126","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1212\/01.wnl.0000345066.57745.50","article-title":"NMO-IgG detected in CSF in seronegative neuromyelitis optica.","volume":"72","author":"Klawiter","year":"2009","journal-title":"Neurology"},{"key":"R50-14-20210126","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"R51-14-20210126","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","article-title":"Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunologic implications.","volume":"66","author":"Kanbayashi","year":"2009","journal-title":"Arch Neurol"},{"key":"R52-14-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","article-title":"Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.","volume":"48","author":"Vernant","year":"1997","journal-title":"Neurology"},{"key":"R53-14-20210126","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/01.wnl.0000183151.19351.82","article-title":"Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.","volume":"65","author":"Misu","year":"2005","journal-title":"Neurology"},{"key":"R54-14-20210126","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2169\/internalmedicine.50.4295","article-title":"Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder.","volume":"50","author":"Ikeda","year":"2011","journal-title":"Intern Med"},{"key":"R55-14-20210126","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.","volume":"72","author":"Magana","year":"2009","journal-title":"Neurology"},{"key":"R56-14-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non-organ-specific autoimmunity.","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"R57-14-20210126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica.","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"R58-14-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"R59-14-20210126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica.","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"key":"R60-14-20210126","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devics disease (neuromyelitis optica) in Mexico.","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol"},{"key":"R61-14-20210126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis.","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"R62-14-20210126","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/archneur.65.11.1546-a","article-title":"Neuromyelitis optica and the optic neuritis treatment trial response to letter.","volume":"65","author":"Smith","year":"2008","journal-title":"Arch Neurol"},{"key":"R64-14-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis. The experience of the Optic Neuritis Treatment Trial.","volume":"111","author":"Keltner","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R65-14-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","article-title":"Devics neuromyelitis optica: clinical, laboratory, MRI and outcome profile.","volume":"197","author":"de Seze","year":"2002","journal-title":"J Neurol Sci"},{"key":"R66-14-20210126","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"R67-14-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0404.2003.02178.x","article-title":"Devics neuromyelitis optica: study of nine cases.","volume":"108","author":"Fardet","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"R68-14-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.survophthal.2007.10.002","article-title":"A woman with unilateral visual loss and bilateral disk edema.","volume":"53","author":"Gilbert","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"R69-14-20210126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2377-10-45","article-title":"Visual field defects of optic neuritis in neuromyelitis optica compared with multiple sclerosis.","volume":"10","author":"Nakajima","year":"2010","journal-title":"BMC Neurol"},{"key":"R70-14-20210126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.","volume":"128","author":"Keltner","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R71-14-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2010.01388.x","article-title":"Bilateral and recurrent optic neuritis in multiple sclerosis.","volume":"123","author":"Burman","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"R72-14-20210126","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis.","volume":"61","author":"Pirko","year":"2004","journal-title":"Arch Neurol"},{"key":"R73-14-20210126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION).","volume":"126","author":"Kidd","year":"2003","journal-title":"Brain"},{"key":"R74-14-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","article-title":"Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.","volume":"81","author":"Petzold","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R75-14-20210126","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/jnnp.2009.183749","article-title":"Functional MRI as a tool for assessing chiasmal visual defect in a patient with neuromyelitis optica.","volume":"81","author":"Raz","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R76-14-20210126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0004-27492007000100029","article-title":"An unusual chiasmal visual field defect in a patient with neuromyelitis optica: case report.","volume":"70","author":"da Silva Costa","year":"2007","journal-title":"Arq Bras Oftalmol"},{"issue":"suppl 4","key":"R77-14-20210126","first-page":"A388","article-title":"DTI tractography correlates with OCT and confirms hemi-field defect: a unique presentation of post-chiasmatic neuromyelitis optica.","volume":"76","author":"Romero","year":"2011","journal-title":"Neurology"},{"key":"R78-14-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/WNO.0b013e31821d549b","article-title":"Ocular oscillations in the neuromyelitis optica spectrum.","volume":"31","author":"Hage","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R79-14-20210126","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458510391690","article-title":"Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody.","volume":"17","author":"SShinoda","year":"2011","journal-title":"Mult Scler"},{"key":"R80-14-20210126","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jocn.2010.12.052","article-title":"Prominent brainstem symptomssigns in patients with neuromyelitis optica in a Taiwanese population.","volume":"18","author":"Wang","year":"2011","journal-title":"J Clin Neurosci"},{"key":"R81-14-20210126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1352458511414149","article-title":"Cortical oscillopsia without nystagmus, an isolated symptom of neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibody.","volume":"18","author":"Kim","year":"2012","journal-title":"Mult Scler"},{"key":"R82-14-20210126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.","volume":"298","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"R83-14-20210126","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis.","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"R84-14-20210126","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archopht.126.4.566","article-title":"NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis.","volume":"126","author":"Dinkin","year":"2008","journal-title":"Arch Opthalmol"},{"key":"R85-14-20210126","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1212\/01.wnl.0000313843.78606.cd","article-title":"To test or not to test: NMO-IgG and optic neuritis.","volume":"70","author":"Giovannoni","year":"2008","journal-title":"Neurology"},{"key":"R86-14-20210126","first-page":"376","article-title":"Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment J Neuroophthalmol.","volume":"30","author":"Galetta","year":"2010","journal-title":""},{"key":"R88-14-20210126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/jnnp.2009.193888","article-title":"The borderland of neuromyelitis optica.","volume":"9","author":"Matthews","year":"2009","journal-title":"Pract Neurol"},{"key":"R89-14-20210126","doi-asserted-by":"crossref","first-page":"e23489","DOI":"10.1371\/journal.pone.0023489","article-title":"The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis.","volume":"6","author":"Storoni","year":"2011","journal-title":"PLoS One"},{"key":"R90-14-20210126","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1167\/iovs.08-1815","article-title":"Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica.","volume":"49","author":"Merle","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R91-14-20210126","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","article-title":"Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.","volume":"73","author":"Ratchford","year":"2009","journal-title":"Neurology"},{"key":"R92-14-20210126","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","article-title":"Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.","volume":"72","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"R93-14-20210126","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00417-010-1344-7","article-title":"Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.","volume":"248","author":"Nakamura","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R94-14-20210126","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/archneur.65.7.920","article-title":"Optical coherence tomography in neuromyelitis optica.","volume":"65","author":"de Seze","year":"2008","journal-title":"Arch Neurol"},{"key":"R95-14-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awr264","article-title":"Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.","volume":"135","author":"Syc","year":"2012","journal-title":"Brain"},{"issue":"suppl 4","key":"R96-14-20210126","first-page":"A64","article-title":". Longitudinal follow-up of vision in a neuromyelitis cohort.","volume":"76","author":"Bouyon","year":"2011","journal-title":"Neurology"},{"key":"R97-14-20210126","first-page":"749","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"R98-14-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"R99-14-20210126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2009.02.371","article-title":"Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients.","volume":"281","author":"Watanabe","year":"2009","journal-title":"J Neurol Sci"},{"key":"R100-14-20210126","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/1352458510396923","article-title":"High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.","volume":"17","author":"Collongues","year":"2011","journal-title":"Mult Scler"},{"key":"R101-14-20210126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0404.2008.01012.x","article-title":"Brain magnetic resonance imaging abnormalities in neuromyelitis optica.","volume":"118","author":"Li","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"R103-14-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-008-0007-z","article-title":"Neuromyelitis optica.","volume":"10","author":"Wingerchuk","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"R104-14-20210126","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute CNS inflammatory demyelinating disease.","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"R105-14-20210126","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","article-title":"Plasma exchange for severe optic neuritis: treatment of 10 patients.","volume":"63","author":"Ruprecht","year":"2004","journal-title":"Neurology"},{"key":"R106-14-20210126","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","article-title":"Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.","volume":"67","author":"Palace","year":"2010","journal-title":"Arch Neurol"},{"key":"R107-14-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","article-title":"Failure of natalizumab to prevent relapses in neuromyelitis optica.","volume":"69","author":"Kleiter","year":"2012","journal-title":"Arch Neurol"},{"key":"R108-14-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","article-title":"Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.","volume":"18","author":"Min","year":"2012","journal-title":"Mult Scler"},{"key":"R109-14-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devics neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"R110-14-20210126","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e31822a2780","article-title":"Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.","volume":"77","author":"Costanzi","year":"2011","journal-title":"Neurology"},{"key":"R111-14-20210126","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"R112-14-20210126","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica.","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"R113-14-20210126","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"R115-14-20210126","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"R116-14-20210126","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1096\/fj.11-201608","article-title":"Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.","volume":"26","author":"Tradtrantip","year":"2012","journal-title":"FASEB J"},{"key":"R117-14-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis opticaimmunoglobulin G-induced damage in mouse.","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann Neurol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e31825662f1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T01:39:34Z","timestamp":1642297174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201206000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e31825662f1","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}